Skip to main content

View full-text article in PMC

. 2011 Dec 30;17(1):341–354. doi: 10.3390/molecules17010341

Table 5.

Effects of sevoflurane postconditioning on serum and brain SOD, CAT, GSH-Px and GR activities.

Group	SOD		CAT
Group	Serum (U/mL)	Brain (U/mg)	Serum (U/mL)	Brain (U/mg)
I	276.5 ± 16.3	303.1 ± 22.9	39.11 ± 1.54	33.12 ± 1.84
II	132.1 ± 9.6 ^b	137.4 ± 10.7 ^b	15.03 ± 1.11 ^b	12.84 ± 1.02 ^b
III	176.4 ± 8.6 ^d	199.2 ± 12.4 ^d	19.99 ± 2.09 ^d	21.87 ± 1.15 ^d
IV	220.6 ± 11.6 ^d	274.8 ± 17.3 ^d	24.08 ± 1.57 ^d	28.44 ± 1.36 ^d
V	281.5 ± 20.5 ^d	314.1 ± 19.2 ^d	34.17 ± 1.72 ^d	32.17 ± 1.83 ^d
Group	GSH-Px		GR
Group	Serum (U/mL)	Brain (U/mg)	Serum (U/mL)	Brain (U/mg)
I	52.19 ± 2.54	63.19 ± 2.98	29.07 ± 1.54	32.18 ± 1.76
II	22.15 ± 1.54 ^b	27.51 ± 1.06 ^b	12.16 ± 1.06 ^b	15.27 ± 1.13 ^b
III	32.97 ± 1.97 ^d	37.82 ± 1.44 ^d	19.03 ± 1.17 ^d	21.54 ± 1.08 ^d
IV	40.63 ± 2.61 ^d	47.18 ± 2.31 ^d	24.01 ± 1.32 ^d	29.41 ± 1.57 ^d
V	49.76 ± 2.88 ^d	58.29 ± 2.28 ^d	32.18 ± 1.69 ^d	34.29 ± 1.39 ^d

Values are given as mean ± SD from six rats in each group. ^b p < 0.01, compared with group I; ^d p < 0.01, compared with group II.